Dataset summary
| TF Name: | TCF7L2 | Species: | Homo sapiens |
| Cell-type/Tissue: | HeLa S3 (cervical adenocarcinoma) | Condition/Source: | |
| JASPAR ID: | MA0523.1 | Collections: | Permissive Robust |
| References: | ENCODE ENCSR000EVF GTRD EXP010241 | ||
External links
Statistical details
| Model | Peak caller | Model ID | Enrichment Zone | TFBSs | Score threshold | Centrality p-value (log10) |
|---|---|---|---|---|---|---|
| DAMO | MACS | MA0523.1 | 75.5 | 2205 | 84.7 | -45.2514699174169 |
30 datasets found for the same TF (TCF7L2) in other cell-types/tissues
| TF Name | Cell-line | Condition/Source | Collections | Species | Identifiers | JASPAR ID |
|---|---|---|---|---|---|---|
| TCF7L2 | U937 (adult acute monocytic leukemia) | bio | Permissive | Homo sapiens | GSE29195 ... | MA0523.1 |
| TCF7L2 | K562 (myelogenous leukemia) | bio | Permissive Robust | Homo sapiens | GSE29195 ... | MA0523.1 |
| TCF7L2 | H4-II-E (hepatocellular carcinoma) | siRNA - Scrambled | Permissive Robust | Rattus norvegicus | GSE53862 ... | MA0523.1 |
| TCF7L2 | H4-II-E (hepatocellular carcinoma) | siRNA -Tcf7l2 | Permissive Robust | Rattus norvegicus | GSE53862 ... | MA0523.1 |
| TCF7L2 | oligodendrocyte progenitors | proliferation medium | Permissive | Rattus norvegicus | GSE65119 ... | MA0523.1 |
| TCF7L2 | oligodendrocyte progenitors | T3 treated for 1 day | Permissive Robust | Rattus norvegicus | GSE65119 ... | MA0523.1 |
| TCF7L2 | oligodendrocyte progenitors | T3 treated for 3 days | Permissive Robust | Rattus norvegicus | GSE65119 ... | MA0523.1 |
| TCF7L2 | crypt cells | Ring KO | Permissive | Mus musculus | GSE65318 ... | MA0523.1 |
| TCF7L2 | cardiac ventricles | Treatment: 12 weeks-old adult mice were administered with TX 30mg/Kg/day for 3 days , sacrificed 3 weeks-post induction Strain: C57BL/6 Genotype: alphaMHC Cre recombinase positive, beta-catenin exon3 deleted-stabilized beta-catenin (transgenic) | Permissive Robust | Mus musculus | GSE97761 ... | MA0523.1 |
| TCF7L2 | cardiac ventricles | Treatment: 12 weeks-old adult mice were administered with TX 30mg/Kg/day for 3 days , sacrificed 3 weeks-post induction Strain: C57BL/6 Genotype: alphaMHC Cre recombinase positive, beta-catenin exon3 deleted-stabilized beta-catenin (transgenic) | Permissive Robust | Mus musculus | GSE97761 ... | MA0523.1 |
| TCF7L2 | CD34+ cells | PROG_BIO | Permissive Robust | Homo sapiens | GSE29194 | MA0523.1 |
| TCF7L2 | HCT-116 (colon carcinoma) | Permissive Robust | Homo sapiens | ENCSR000EUV | MA0523.1 | |
| TCF7L2 | HEK293 (embryonic kidney) | Permissive Robust | Homo sapiens | ENCSR000EUY | MA0523.1 | |
| TCF7L2 | HeLa S3 (cervical adenocarcinoma) | Permissive Robust | Homo sapiens | ENCSR000EVE | MA0523.1 | |
| TCF7L2 | HepG2 (hepatoblastoma) | Permissive Robust | Homo sapiens | ENCSR000EVQ | MA0523.1 | |
| TCF7L2 | MCF7 (Invasive ductal breast carcinoma) | Permissive Robust | Homo sapiens | ENCSR000EWT | MA0523.1 | |
| TCF7L2 | PANC1 (pancreatic ductal adenocarcinoma) | Permissive Robust | Homo sapiens | ENCSR000EXL | MA0523.1 | |
| TCF7L2 | hair follicle stem cells | Permissive Robust | Mus musculus | GSE48878 ... | MA0523.1 | |
| TCF7L2 | hepatocytes | Permissive | Mus musculus | GSE35213 ... | MA0523.1 | |
| TCF7L2 | H4-II-E (hepatocellular carcinoma) | Permissive Robust | Rattus norvegicus | GSE28782 ... | MA0523.1 | |
| TCF7L2 | crypt cells | Permissive Robust | Mus musculus | GSE65318 ... | MA0523.1 | |
| TCF7L2 | small intestine | Permissive | Mus musculus | GSE71946 ... | MA0523.1 | |
| TCF7L2 | HUES64 (embryonic stem cells) | Permissive Robust | Homo sapiens | GSE61475 ... | MA0523.1 | |
| TCF7L2 | HUES64 (embryonic stem cells) | Permissive Robust | Homo sapiens | GSE61475 ... | MA0523.1 | |
| TCF7L2 | HUES64 (embryonic stem cells) | Permissive Robust | Homo sapiens | GSE61475 ... | MA0523.1 | |
| TCF7L2 | HUES64 (embryonic stem cells) | Permissive Robust | Homo sapiens | GSE61475 ... | MA0523.1 | |
| TCF7L2 | K562 (myelogenous leukemia) | Permissive | Homo sapiens | ENCSR888XZK | MA0523.1 | |
| TCF7L2 | LNCaP (prostate carcinoma) | Permissive Robust | Homo sapiens | GSE51621 | MA0523.1 | |
| TCF7L2 | MDA-MB-453 (breast adenocarcinoma) | DHT | Permissive Robust | Homo sapiens | GSE45201 | MA0523.1 |
| TCF7L2 | MDA-MB-453 (breast adenocarcinoma) | Permissive | Homo sapiens | GSE45201 | MA0523.1 |